Clarify the Role of Semaglutide for Chronic Kidney Disease
October 2024
You’ll see more semaglutide use for chronic kidney disease (CKD) in patients with type 2 diabetes.
We know that some injectable GLP-1 agonists (dulaglutide, liraglutide, semaglutide) may slow CKD progression.
But previous studies either didn’t focus on CKD and diabetes together...or benefits in CKD were only secondary outcomes.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive